Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Contamination Issues Drove Drug Recalls to Record Levels in 2011

This article was originally published in The Gold Sheet

Executive Summary

How contamination, sterility assurance, OOS and other issues caused drug recalls to spike again last year. What happened at Aidapak, H&P, Ben Venue, Hospira, Teva and other manufacturers to set a new record.


Related Content

APP Pharmaceuticals, Praised For Easing Drug Shortages, Gets Manufacturing Warning Letter
FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations
Glass Quality Crisis Prompts Multi-Faceted Array of Risk-Based Improvements
Another Busy Year of Drug Recalls Led to Shortages of Injectables
Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters
Record Drug Recall Totals for 2009 Resulted from GMP Breakdowns
Advantage Dose's GMP Issues Mirrored Earlier Problems Affecting Repackers
Using Third-Party Repackagers Improves Hospital Patient Safety, Experts Say
Data Integrity Problems Continued to Surface in Recent Warning Letters
McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts